Produk

Sandoo minangka Ketorolac Trometamol, Olopatadine Hydrochloride, Vancomycin Hydrochloride produsen lan pemasok sing apik ing China. Pabrik kita wis fokus ing API, anti-kanker, intermediet obat antivirus, bahan kimia sing apik, ekspor lan impor aditif panganan luwih saka 10 taun, lan produk kita nutupi kabeh ndonya, kayata Amerika Serikat, Kanada, Inggris. , Prancis, lsp., lan mboko sithik nutupi luwih saka 20 negara ing saindenging jagad.
View as  
 
Tert-Butyl [(1R,2S,5S)-2-Amino-5-[(Dimethylamino)Carbonyl]Cyclohexyl]Carbamate Oxalate

Tert-Butyl [(1R,2S,5S)-2-Amino-5-[(Dimethylamino)Carbonyl]Cyclohexyl]Carbamate Oxalate

Nama Produk: Tert-Butyl [(1R,2S,5S)-2-Amino-5-[(Dimethylamino)Carbonyl]Cyclohexyl]Carbamate Oxalate
Formula Molekul: C14H27N3O3.C2H2O4
Bobot Molekul: 375.42
Nomer CAS: 1210348-34-7
Dianggo: Edoxaban Tosylate Monohydrate

Waca liyaneKirim Pitakonan
5-Metil-4,5,6,7-Tetrahydrothiazolo[5,4-c]Pyridine-2-Carboxylic acid Hydrochloride

5-Metil-4,5,6,7-Tetrahydrothiazolo[5,4-c]Pyridine-2-Carboxylic acid Hydrochloride

Nama Produk: 5-Methyl-4,5,6,7-Tetrahydrothiazolo[5,4-c]Pyridine-2-Carboxylic Acid Hydrochloride
Formula Molekul: C8H10N2O2S.HCl
Bobot Molekul: 234.70
Nomer CAS: 720720-96-7
Dianggo: Edoxaban Tosylate Monohydrate

Waca liyaneKirim Pitakonan
Etil 2-(3-Formil-4-Isobutoxyphenyl)-4-Metiltiazol-5-Karboksilat

Etil 2-(3-Formil-4-Isobutoxyphenyl)-4-Metiltiazol-5-Karboksilat

Nama Produk: Ethyl 2-(3-Formil-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate
Formula Molekul: C18H21NO4S
Bobot Molekul: 347.43
Nomer CAS: 161798-03-4
Dianggo: Febuxostat

Waca liyaneKirim Pitakonan
Etil 2-(3-Formil-4-Hidroksifenil)-4-Metiltiazol-5-Karboksilat

Etil 2-(3-Formil-4-Hidroksifenil)-4-Metiltiazol-5-Karboksilat

Nama Produk: Ethyl 2-(3-Formil-4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate
Formula Molekul: C14H13NO4S
Bobot Molekul: 291.32
NOMER CAS: 161798-01-2
Dianggo: Febuxostat

Waca liyaneKirim Pitakonan
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept